Immunopathology and immunotherapy of hodgkin lymphoma

Maryam Ebadi, Yi Zeng, Maria Gkotzamanidou, Nima Rezaei

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Immunotherapy has led to promising results in the treatment of malignancies in recent decades. In view of the suboptimal results obtained by applying other treatment modalities in the treatment of Hodgkin lymphoma (HL), attention has been drawn to immunotherapy as an efficient alternative or complement therapy. This chapter seeks to discuss a wide spectrum of immunotherapeutic approaches, from initial monoclonal antibodies to novel techniques developed in recent years, which are still at their infancy. Since correct understanding of the underlying immunopathology seems inevitable in efficient immunotherapy and the development of future techniques, a brief description with the emphasis on suitable targets for immunotherapy is given before discussing various immunotherapies.

Original languageEnglish (US)
Title of host publicationCancer Immunology
Subtitle of host publicationCancer Immunotherapy for Organ-Specific Tumors
PublisherSpringer Berlin Heidelberg
Pages117-134
Number of pages18
ISBN (Electronic)9783662464106
ISBN (Print)9783662464090
DOIs
StatePublished - Jan 1 2015

Keywords

  • Hodgkin
  • Immunopathology
  • Immunotherapy
  • Lymphoma

ASJC Scopus subject areas

  • Medicine(all)
  • Immunology and Microbiology(all)

Fingerprint Dive into the research topics of 'Immunopathology and immunotherapy of hodgkin lymphoma'. Together they form a unique fingerprint.

  • Cite this

    Ebadi, M., Zeng, Y., Gkotzamanidou, M., & Rezaei, N. (2015). Immunopathology and immunotherapy of hodgkin lymphoma. In Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (pp. 117-134). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-662-46410-6_7